-
1
-
2
-
3
Abstract OT1-14-01: Zanidatamab in combination with ALX148 in advanced human epidermal growth factor receptor 2 (HER2)-expressing cancers, including breast cancer: A phase 1b/2, multicenter, open-label, dose-finding and cohort-expansion study (ZWI-ZW25-204)
Veröffentlicht in Cancer research (Chicago, Ill.)
VolltextArtikel -
4
-
5
Pathways to "evidence-informed" policy and practice: a framework for action
Veröffentlicht in PLoS medicine
VolltextArtikel -
6
-
7
-
8
Migration and health: a global public health research priority
Veröffentlicht in BMC public health
VolltextArtikel -
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20